Is The Cooper Companies, Inc (COO) overvalued? · P/E 36, rev $4.09B
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
This page asks whether The Cooper Companies, Inc (COO) looks expensive on cached numbers — not a short thesis.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. Revenue was up 5.1% from 2024-10-31 to 2025-10-31. COO currently screens at market cap $14.92B and trailing P/E 36.1.
COO currently screens at market cap $14.92B and trailing P/E 36.1. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next COO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the COO stock page for the full model, not this heading.
Not investment advice.